483 related articles for article (PubMed ID: 32718713)
1. Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience.
Jiménez-Brítez G; Ruiz P; Soler X
Med Clin (Barc); 2020 Nov; 155(9):410-411. PubMed ID: 32718713
[No Abstract] [Full Text] [Related]
2. Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab.
De Luna G; Habibi A; Deux JF; Colard M; Pham Hung d'Alexandry d'Orengiani AL; Schlemmer F; Joher N; Kassasseya C; Pawlotsky JM; Ourghanlian C; Michel M; Mekontso-Dessap A; Bartolucci P
Am J Hematol; 2020 Jul; 95(7):876-878. PubMed ID: 32282956
[No Abstract] [Full Text] [Related]
3. Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study.
Ramiro S; Mostard RLM; Magro-Checa C; van Dongen CMP; Dormans T; Buijs J; Gronenschild M; de Kruif MD; van Haren EHJ; van Kraaij T; Leers MPG; Peeters R; Wong DR; Landewé RBM
Ann Rheum Dis; 2020 Sep; 79(9):1143-1151. PubMed ID: 32719045
[TBL] [Abstract][Full Text] [Related]
4. COVID-19: Some clinical questions after the first 4 months.
Bassetti M; Ansaldi F; Icardi G; Pelosi P; Robba C; Taramasso L; Trucchi C; Vena A; Giacobbe DR
Eur J Clin Invest; 2020 Jul; 50(7):e13326. PubMed ID: 32562550
[No Abstract] [Full Text] [Related]
5. Tocilizumab administration in a refractory case of COVID-19.
Dastan F; Nadji SA; Saffaei A; Tabarsi P
Int J Antimicrob Agents; 2020 Aug; 56(2):106043. PubMed ID: 32502524
[No Abstract] [Full Text] [Related]
6. May IL-17 have a role in COVID-19 infection?
Megna M; Napolitano M; Fabbrocini G
Med Hypotheses; 2020 Jul; 140():109749. PubMed ID: 32339777
[No Abstract] [Full Text] [Related]
7. Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes.
Price CC; Altice FL; Shyr Y; Koff A; Pischel L; Goshua G; Azar MM; Mcmanus D; Chen SC; Gleeson SE; Britto CJ; Azmy V; Kaman K; Gaston DC; Davis M; Burrello T; Harris Z; Villanueva MS; Aoun-Barakat L; Kang I; Seropian S; Chupp G; Bucala R; Kaminski N; Lee AI; LoRusso PM; Topal JE; Dela Cruz C; Malinis M
Chest; 2020 Oct; 158(4):1397-1408. PubMed ID: 32553536
[TBL] [Abstract][Full Text] [Related]
8. Bloodstream infections in critically ill patients with COVID-19.
Giacobbe DR; Battaglini D; Ball L; Brunetti I; Bruzzone B; Codda G; Crea F; De Maria A; Dentone C; Di Biagio A; Icardi G; Magnasco L; Marchese A; Mikulska M; Orsi A; Patroniti N; Robba C; Signori A; Taramasso L; Vena A; Pelosi P; Bassetti M
Eur J Clin Invest; 2020 Oct; 50(10):e13319. PubMed ID: 32535894
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge.
Carnero Contentti E; Correa J
Mult Scler Relat Disord; 2020 Jun; 41():102097. PubMed ID: 32278860
[No Abstract] [Full Text] [Related]
10. Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab.
Gautier-Vargas G; Baldacini C; Benotmane I; Keller N; Perrin P; Moulin B; Caillard S
Kidney Int; 2020 Aug; 98(2):508-509. PubMed ID: 32505467
[No Abstract] [Full Text] [Related]
11. Interleukin-6 blockade treatment for COVID-19 associated cytokine release syndrome in a patient with poorly controlled chronic myeloid leukaemia.
Ranger A; Haji R; Kaczmarski R; Danga A
Br J Haematol; 2020 Aug; 190(3):e128-e130. PubMed ID: 32480422
[No Abstract] [Full Text] [Related]
12. Experience in the management of severe COVID-19 patients in an intensive care unit.
Sosa-García JO; Gutiérrez-Villaseñor AO; García-Briones A; Romero-González JP; Juárez-Hernández E; González-Chon O
Cir Cir; 2020; 88(5):569-575. PubMed ID: 33064694
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndrome.
Hoiland RL; Stukas S; Cooper J; Thiara S; Chen LYC; Biggs CM; Hay K; Lee AYY; Shojania K; Abdulla A; Wellington CL; Sekhon MS
Br J Haematol; 2020 Aug; 190(3):e150-e154. PubMed ID: 32584416
[No Abstract] [Full Text] [Related]
14. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
Mikulska M; Nicolini LA; Signori A; Di Biagio A; Sepulcri C; Russo C; Dettori S; Berruti M; Sormani MP; Giacobbe DR; Vena A; De Maria A; Dentone C; Taramasso L; Mirabella M; Magnasco L; Mora S; Delfino E; Toscanini F; Balletto E; Alessandrini AI; Baldi F; Briano F; Camera M; Dodi F; Ferrazin A; Labate L; Mazzarello G; Pincino R; Portunato F; Tutino S; Barisione E; Bruzzone B; Orsi A; Schenone E; Rosseti N; Sasso E; Da Rin G; Pelosi P; Beltramini S; Giacomini M; Icardi G; Gratarola A; Bassetti M
PLoS One; 2020; 15(8):e0237831. PubMed ID: 32817707
[TBL] [Abstract][Full Text] [Related]
15. Outcome of non-invasive ventilation in COVID-19 critically ill patients: A Retrospective observational Study.
Mukhtar A; Lotfy A; Hasanin A; El-Hefnawy I; El Adawy A
Anaesth Crit Care Pain Med; 2020 Oct; 39(5):579-580. PubMed ID: 32736030
[No Abstract] [Full Text] [Related]
16. Colorectal surgery obesity-related morbidity during COVID-19.
Montorfano L; Miret R; Rahman AU; Alonso M; Maron DJ; Roy M; Ferri F; Bejarano P; Wexner SD
Surg Obes Relat Dis; 2020 Sep; 16(9):1372-1375. PubMed ID: 32723601
[TBL] [Abstract][Full Text] [Related]
17. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.
Zhang C; Wu Z; Li JW; Zhao H; Wang GQ
Int J Antimicrob Agents; 2020 May; 55(5):105954. PubMed ID: 32234467
[TBL] [Abstract][Full Text] [Related]
18. First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab.
Zhang X; Song K; Tong F; Fei M; Guo H; Lu Z; Wang J; Zheng C
Blood Adv; 2020 Apr; 4(7):1307-1310. PubMed ID: 32243501
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal Perforation After Treatment With Tocilizumab : An Unexpected Consequence of COVID-19 Pandemic.
Rojo M; Cano-Valderrama O; Picazo S; Saez C; Gómez L; Sánchez C; Sanz-Ortega G; Torres AJ
Am Surg; 2020 Jun; 86(6):565-566. PubMed ID: 32683974
[No Abstract] [Full Text] [Related]
20. Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report.
Gonzales-Zamora JA; Quiroz T; Vega AD
Medwave; 2020 Aug; 20(7):e7998. PubMed ID: 32876623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
